EFOR
Everforth, Inc.NYSETECHNOLOGYINFORMATION TECHNOLOGY SERVICES
Key Statistics
Market Cap
$799.50M
P/E Ratio
8.67
EPS
$2.25
Beta
0.46
52W High
$60.75
52W Low
$16.90
50-Day MA
$30.01
200-Day MA
$43.15
Dividend Yield
—
Profit Margin
2.47%
Forward P/E
7.49
PEG Ratio
0.64
About Everforth, Inc.
Efoora Inc. develops rapid diagnostic tests and biosensors for testing and diagnosing diseases including HIV, Hepatitis B and C, malaria, pregnancy, bovine spongiform encephalopathy (BSE), and chronic wasting disease (CWD). The company is headquartered in Buffalo Grove, Illinois.
Fundamentals
| Revenue (TTM) | $3.98B |
| Gross Profit (TTM) | $1.14B |
| EBITDA | $356.90M |
| Operating Margin | 4.18% |
| Return on Equity | 5.48% |
| Return on Assets | 4.07% |
| Revenue/Share (TTM) | $93.00 |
| Book Value | $43.32 |
| Price-to-Book | 0.45 |
| Price-to-Sales (TTM) | 0.20 |
| EV/Revenue | 0.532 |
| EV/EBITDA | 6.47 |
| Quarterly Earnings Growth (YoY) | -72.80% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $41.00M |
| Float | $36.94M |
| % Insiders | 3.37% |
| % Institutions | 111.69% |
Analyst Ratings
Consensus ($30.33 target)
1
Buy4
Hold2
SellMore TECHNOLOGY Stocks
Data last updated: 5/25/2026